BIOMAT Database Logo BIOMAT Database Logo

Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody. 1992

F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Department of Internal Medicine I, University Hospital Dykzigt, Erasmus University, Rotterdam, The Netherlands.

Incubation of human plasma prorenin (PR), the enzymatically inactive precursor of renin (EC 3.4.23.15), with a number of nonpeptide high-affinity active site-directed renin inhibitors induces a conformational change in PR, which was detected by a monoclonal antibody that reacts with active renin but not with native inactive PR. This conformational change also occurred when inactive PR was activated during exposure to low pH. Nonproteolytically acid-activated PR, and inhibitor-"activated" PR, as well as native PR, were retained on a blue Sepharose column, in contrast to proteolytically activated PR. Kinetic analysis of the activation of plasma prorenin by renin inhibitor (INH) indicated that native plasma contains an open intermediary form of prorenin, PRoi, in which the active site is exposed and which is in rapid equilibrium with the inactive closed form, PRc. PRoi reacts with inhibitor to form a reversible complex, PRoi.INH, which undergoes a conformational change resulting in a tight complex of a modified open form of prorenin, PRo, and the inhibitor, PRoi.INH-->PRo.INH. The PRoi-to-PRo conversion leads to the expression of an epitope on the renin part of the molecule that is recognized by a renin-specific monoclonal antibody. Presumably, PRo corresponds to the enzymatically active form of PR that is formed during exposure to low pH. Thus, it seems that the propeptide of PR interacts with the renin part of the molecule not only at or near the enzyme's active site but also at some distance from the active site. Interference with the first interaction by renin inhibitor leads to destabilization of the propeptide, by which the second interaction is disrupted and the enzyme assumes its active conformation. The results of this study may provide a model for substrate-mediated prorenin activation and increase the likelihood that enzymatically active prorenin is formed in vivo.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin

Related Publications

F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Identification of plasma inactive renin as prorenin with a site-directed antibody.
January 1985, Biochemical and biophysical research communications,
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Spotlight on renin: Nonproteolytic activation of prorenin by the (pro)renin receptor is blocked by decoy peptide.
June 2007, Journal of the renin-angiotensin-aldosterone system : JRAAS,
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Cardiovascular effects of nonproteolytic activation of prorenin.
December 2006, Hypertension (Dallas, Tex. : 1979),
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Nonallosteric activation of posttranslational modification enzymes by active site-directed inhibitors.
December 2024, Computational and structural biotechnology journal,
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Characterization of a monoclonal antibody specific for human active renin.
March 1992, Hypertension (Dallas, Tex. : 1979),
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity.
July 1996, Clinical chemistry,
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Active site directed inhibitors of replication-specific bacterial DNA polymerases.
February 2005, Bioorganic & medicinal chemistry letters,
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Measurement of active renin by the 4G1 anti-human renin monoclonal antibody.
January 1987, Clinical and experimental hypertension. Part A, Theory and practice,
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Organophosphorus compounds as active site-directed inhibitors of elastase.
August 1978, Biochemical and biophysical research communications,
F H Derkx, and J Deinum, and M Lipovski, and M Verhaar, and W Fischli, and M A Schalekamp
Active site directed inactivators of mouse submaxillary renin.
July 1975, Biochemistry,
Copied contents to your clipboard!